Resting State Functional Connectivity in Cluster Headache
Launched by IRCCS NATIONAL NEUROLOGICAL INSTITUTE "C. MONDINO" FOUNDATION · Jan 4, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding how brain connectivity works in people who suffer from cluster headaches, which are very painful and recurring headaches that often happen in cycles. Researchers want to learn more about the differences in brain activity when patients are experiencing headaches compared to when they are headache-free. They will also compare these findings with healthy volunteers to see how brain function differs in those without headache disorders.
To participate, individuals must be diagnosed with either episodic or chronic cluster headaches and have a history of the condition for at least a year. They cannot be currently taking certain headache prevention medications or have other significant health issues, such as epilepsy or psychiatric disorders. Participants will undergo brain activity recordings during different phases of their headache condition. It's important to note that this study is currently recruiting participants, and both men and women aged between 18 and 75 are eligible to join.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of 3.1.1 episodic cluster headache, or 3.1.2 chronic cluster headache, according to the International Classification of Headache Disorders-3 (ICHD-3) criteria
- • History of at least 1 year of disease
- • For the active-phase recording (T0) in eCH, no preventive medication ongoing or verapamil at a stable dose for at least 2 weeks
- • For the remission-phase recording (T1), no preventive medication ongoing, and at least 14 headache-free days since preventive discontinuation
- Exclusion Criteria:
- • Previous or actual history of epilepsy
- • Diagnosis of dementia o mental retardation
- • Diagnosis of psychiatric illness according to Diagnostic and Statistical Manual of Mental Disorders V
- • Other concomitant type of headache (except for sporadic tension type headache)
- • Chronic pain conditions
- • Pregnancy or breastfeeding
- • Concomitant use of electrical stimulators, pace-makers, metallic clips or other metallic foreign bodies
- • Previous head surgery
- • Ongoing neuroactive prevention therapies or other drugs, or psychoactive substances possibly interfering with EEG recording (eg benzodiazepines)
- • Other conditions possibly influencing EEG recording
- • Brain anomalies detected on MRI
- • Healthy controls (HCs)
- Inclusion Criteria:
- • Age and sex-matched healthy volunteers, without history of headache disorders except sporadic tension-type headache according to ICHD-3 criteria
- Exclusion Criteria:
- • Previous or actual history of epilepsy
- • Diagnosis of dementia o mental retardation
- • Diagnosis of psychiatric illness according to Diagnostic and Statistical Manual of Mental Disorders V
- • Chronic pain conditions
- • Pregnancy or breastfeeding
- • Concomitant use of electrical stimulators, pace-makers, metallic clips or other metallic foreign bodies
- • Previous head surgery
- • Ongoing neuroactive prevention therapies or other drugs, or psychoactive substances possibly interfering with EEG recording (eg benzodiazepines)
- • Other conditions possibly influencing EEG recording
About Irccs National Neurological Institute "C. Mondino" Foundation
The IRCCS National Neurological Institute "C. Mondino" Foundation is a prominent research institution in Italy dedicated to advancing the field of neurology through innovative clinical trials and scientific research. As a recognized IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), the foundation focuses on the diagnosis, treatment, and rehabilitation of neurological disorders, fostering collaboration among healthcare professionals, researchers, and academic institutions. Committed to translating cutting-edge research into clinical practice, the foundation aims to enhance patient care and improve outcomes for individuals affected by neurological diseases. Its rigorous approach to clinical trials ensures the highest standards of scientific integrity and patient safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pavia, , Italy
Patients applied
Trial Officials
Roberto De Icco, MD
Principal Investigator
Headache Science ahd Neurorehabilitation Research Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported